990x120

To Conserve and Protect: The Quest for Universal Vaccines

Viruses such as influenza and SARS-CoV-2 are constantly evolving to better infect their hosts. The appearance of new variants often diminishes the effectiveness of existing vaccines that were designed against pre-existing strains.

In this episode, Niki Spahich from The Scientist’s Creative Services team spoke with Patrick Wilson, a professor at the Gale and Ira Drukier Institute for Children’s Health at Weill Cornell Medicine, to learn about strategies for making universal vaccines that account for pathogen evolution.

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Sino Biological.
 
 

Speaker

Atala.jpg
Patrick Wilson, PhD
Professor
Gale and Ira Drukier Institute for Children’s Health
Weill Cornell Medicine
Sino
Sponsored by Sino Sino Biological is an internationally-recognized reagent supplier and contract research organization, specializing in recombinant protein production and antibody development. Sino Biological has developed the world’s largest recombinant viral antigen bank, ProVir, which has been widely used in therapeutic antibody, vaccine, and immunodiagnostic assay development. For more information, please visit www.sinobiological.com to learn more.

Listen Now

TS_Podcast_TSS_August 2021_The Reality of Regenerative Medicine


Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these podcasts free of charge for our readers.